Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

More documents

Recommendations

Info

146Annual Report on Lymphatic Filariasis 2003ANNEXES Annex 4 Abbreviations and definitionsABBREVIATIONSADLAFESDAFROAMROAPIAPOCAusAIDCDCCDDCDSCEECFACOMBICPEDANIDADECDFIDDMOEMROGAELFGLPGMPGPELFGSKGTZHPLCICFICTIECIUJICAJOCVLFLYMFASIMMDAMDPMEC/ACmfNFCPPacCAREPacELFPAHOPCRPELFPRGA N N E X E SANNEX 4: ABBREVIATIONS AND DEFINITIONSadenolymphangitisArab Fund for Economic and Social DevelopmentWHO Regional Office for AfricaWHO Regional Office for the Americasactive pharmaceutical ingredientAfrican Programme for Onchocerciasis ControlAustralian Agency for International DevelopmentUnited States Centers for Disease Control and Preventioncommunity drug distributorCommunicable Diseases Cluster (WHO)Strategy Development and Monitoring for Elimination and Eradication Unit (WHO)circulating filarial antigencommunication for behavioural impactDepartment for Communicable Disease Control Prevention and Eradication (WHO)Danish International Development Agencydiethylcarbamazine citrateDepartment for International Development of the United Kingdomdistrict medical officerWHO Regional Office for the Eastern MediterraneanGlobal Alliance to Eliminate Lymphatic Filariasisgood laboratory practicesgood manufacturing practicesGlobal Programme to Eliminate Lymphatic FilariasisGlaxoSmithKlineGesellschaft für Technische Zusammenarbeit (German Technical Cooperation)high-pressure liquid chromatographyWHO International Classification of Functioning, Disability and Healthimmuno-chromatographic testinformation, education and communicationimplementation unitJapan International Cooperation AgencyJapanese Overseas Cooperation Volunteerslymphatic filariasisa mathematical model of the transmission and control of LFmass drug administrationMectizan® Donation ProgramMectizan® Expert Committee/Albendazole CoordinationmicrofilaraemiaNational Filariasis Control ProgrammePacELF Coordinating and Review GroupPacific Initiative for the Elimination of Lymphatic FilariasisPan American Health OrganizationPolymerase chain reactionProgramme to Eliminate Lymphatic FilariasisProgramme Review Group
147RAPLOARPRGSAESEAROTAG-LFTDRUNDPUNICEFUSAIDVSOWHOWHODASWPROa method of rapid assessment of loiasis using a simple questionnaireRegional Programme Review Groupserious adverse experienceWHO Regional Office for South-East AsiaTechnical Advisory Group on the Global Elimination of Lymphatic FilariasisUNICEF/UNDP/World Bank/WHO Special Programme for Researchand Training in Tropical DiseasesUnited Nations Development ProgrammeUnited Nations Children’s FundUnited States Agency for International DevelopmentVoluntary Service OverseasWorld Health OrganizationWHO Disability Assessment ScheduleWHO Regional Office for the Western PacificAnnual Report on Lymphatic Filariasis 2003ANNEXES Annex 4 Abbreviations and definitions
Page 1 and 2:
For further information about lymph
Page 3:
WHO/CDS/CPE/CEE/2005.52GlobalProgra
Page 7 and 8:
3Report of the Technical Advisory G
Page 9 and 10:
P R O G R A M M E H I G H L I G H T
Page 11:
I N T R O D U C T I O N7This Annual
Page 14 and 15:
10Annual Report on Lymphatic Filari
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
38Figure 3.2 Outcomes and planning
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 59 and 60:
UNITED REPUBLIC OF TANZANIA55Endemi
Page 61 and 62:
ZANZIBAR, UNITED REPUBLIC OF TANZAN
Page 63:
59AMERICAN PROGRAMME REVIEWGROUPAt
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
82Figure 3.100 Outcomes and plannin
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101: 96Annual Report on Lymphatic Filari
Page 102 and 103: 98Annual Report on Lymphatic Filari
Page 104 and 105: 100Annual Report on Lymphatic Filar
Page 118 and 119: 114Figure 3.196 Outcomes and planni
Page 127: C H A P T E R 6FURTHER DOCUMENTATIO
Page 135 and 136: ANNUAL REPORT FOR THE NATIONAL PROG
Page 137 and 138: 1332. PROGRAMME RESOURCES2.1 Please
Page 139 and 140: 1353.3 Interruption of transmission
Page 141 and 142: 1373.3.6a Report of MDA coverage by
Page 143 and 144: 1393.3.7 Surveys in sentinel sites
Page 145 and 146: 1413.3.10 Please attach a map of th
Page 147 and 148: 1434. SERIOUS ADVERSE EXPERIENCES (
Page 149: A N N E X E SANNEX 3: LIST OF LF-EN
Page 153 and 154: 149Drug administration and monitori
show all

Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?